Follow us on:

Dr. Mordechai Gerlic’s Paper on the Cover of The FEBS Journal

IL-33 is a pro-inflammatory cytokine that plays a role in a range of inflammatory diseases. 

To date, the mechanism underlying its release in cells is not fully understood.

A recent work led by MD/PhD student Inabr Shlomovitz and Dr. Motti Gerlic demonstrate that necroptosis, a form of cell death, triggers the release of IL-33 in its bioactive form. Inhibition of necroptosis in an Aspergillus allergic asthma model results in reduced inflammation, providing in vivo evidence that necroptosis contributes to IL-33-associated inflammatory disease.

Tags:

Trackback from your site.

Subscribe to our newsletter!

What is 7+4?

(You agree that Canadian Friends of Tel Aviv University may collect, use and disclose your personal data which you have provided in this form, for providing marketing material that you have agreed to receive, in accordance with our data protection policy.)

CFTAU Ontario & Western Canada
3130 Bathurst Street, Suite, 214, Toronto, ON | M6A 2A1 | Phone: 416.787.9930
Email: toronto@cftau.ca

CFTAU Ottawa, Quebec and Atlantic Canada
6900 Boulevard Décarie, Suite 3480, Montreal, QC | H3X 2T8 | Phone: 514.344.3417
Email: montreal@cftau.ca

Terms and ConditionsPrivacy • © 2017 CFTAU